Endothelial Cell Markers

Endothelial cells line the interior of all blood vessels, composing the endothelium. All endothelial cells are derived from a common angioblast precursor and subsequently develop organ specific properties. Embryonic endothelial cells exhibit much heterogeneity within, and between, organs. Differentiation of endothelial cells is governed by several factors, including the immediate microenvironment, interactions with surrounding cells, and the local release of cytokines and growth factors. Adult endothelial cells retain remarkable plasticity and are known to reprogram in response to IL-1, TNF, VEGF, and FGF. Because endothelial cells provide many essential functions, endothelial dysfunction leads to vascular disease and can promote the development of chronic inflammatory conditions, such as atherosclerosis. R&D Systems offers a range of quality products for the identification and characterization of specific endothelial cell types.

Neurotransmitter Receptors on Endothelial Cells

5-HT Receptors on Endothelial Cells
5-HT1B5-HT1B Receptor Agonists5-HT1B Receptor Antagonists5-HT1D5-HT1D Receptor Agonists
5-HT1D Receptor AntagonistsNon-selective 5-HT1 Receptor Agonists5-HT2A5-HT2A Receptor Agonists5-HT2A Receptor Antagonists
5-HT2B5-HT2B Receptor AntagonistsNon-selective 5-HT2 Receptor Antagonists5-HT45-HT4 Receptor Agonists
5-HT4 Receptor Antagonists5-HT7 Receptor Agonists5-HT7 Receptor AntagonistsAdditional 5-HT7 Receptor ProductsNon-selective 5-HT Receptor Agonists
5-HT Transporter Inhibitors5-HT Transporter CompoundsAdditional 5-HT-Related Compounds5-HT7 
Adrenergic Receptors on Endothelial Cells
Adrenergic alpha-1 Receptor AgonistsAdrenergic alpha-1 Receptor Antagonistsalpha-1D Adrenergic R/ADRA1D  
Dopamine Receptors on Endothelial Cells
Dopamine D1 and D5 Receptor AgonistsDopamine D1 and D5 Receptor AntagonistsDopamine D1R/DRD1Non-selective Dopamine Receptor AgonistsNon-selective Dopamine Receptor Antagonists
Non-selective Dopamine Receptor ProductsDopamine Transporter InhibitorsDopaminergic-related InhibitorsAdditional Dopaminergic-related Products 
Nicotinic Acetylcholine Receptors and Modulators
Ly6HNicotinic (a4b2) Receptor AgonistsNicotinic (a4b2) Receptor AntagonistsNicotinic (a4b2) Receptor ModulatorsAdditional Nicotinic (a4b2) Receptor Compounds
Nicotinic (a7) Receptor AgonistsNicotinic (a7) Receptor AntagonistsNicotinic (a7) Receptor ModulatorsNicotinic Acetylcholine R alpha 1/CHRNA1Nicotinic Acetylcholine R alpha 2/CHRNA2
Nicotinic Acetylcholine R alpha 3/CHRNA3Nicotinic Acetylcholine R alpha 4/CHRNA4Nicotinic Acetylcholine R alpha 5/CHRNA5Nicotinic Acetylcholine R alpha 7/CHRNA7Nicotinic Acetylcholine R alpha 9/CHRNA9
Nicotinic Acetylcholine R alpha 10/CHRNA10Nicotinic Acetylcholine R alpha 6/CHRNA6Nicotinic Acetylcholine R beta 1/CHRNB1Nicotinic Acetylcholine R beta 2/CHRNB2Nicotinic Acetylcholine R beta 3/CHRNB3
Nicotinic Acetylcholine R beta 4/CHRNB4Nicotinic Acetylcholine R delta/CHRNDNicotinic Acetylcholine R epsilon/CHRNENicotinic Acetylcholine R gamma/CHRNGNicotinic Acid Receptor (GPR109) Agonists
Other Nicotinic Receptor AgonistsOther Nicotinic Receptor ModulatorsAdditional Nicotinic Receptor AgonistsAdditional Nicotinic Receptor AntagonistsSLURP2
Opioid Receptors
delta Opioid R/OPRD1delta Opioid Receptor Agonistsdelta Opioid Receptor Antagonistsdelta Opioid Receptor ModulatorsGPR8/NPBWR2
Kappa Opioid Receptor AgonistsKappa Opioid Receptor Antagonistsmu Opioid R/OPRM1mu Opioid Receptor Agonistsmu Opioid Receptor Antagonists
Miscellaneous/Non-selective Opioid AgonistsMiscellaneous/Non-selective Opioid AntagonistsNOP Receptor AgonistsNOP Receptor Antagonists